Regeneron Pharmaceuticals (60) | Uncategorized (8)

Recent Contracts

Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on February 8, 2021)
Project Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on November 5, 2020)
Base Agreement, dated as of July 6, 2020, by and between the Registrant and Advanced Technology International (Filed With SEC on November 5, 2020)
Amendment to the Amended and Restated Investor Agreement, dated as of May 25, 2020, by and among Regeneron Pharmaceuticals, Inc., Sanofi, Sanofi-Aventis US LLC, and Aventisub LLC (Filed With SEC on May 29, 2020)
Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 7, 2020)
Second Amendment Agreement, dated December 19, 2019, by and between Bayer HealthCare LLC and the Registrant (Filed With SEC on February 7, 2020)
Investor Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)
Master Agreement, dated as of April 8, 2019, by and between the Registrant and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 6, 2019)